ATCC® Genuine Nucleics

DNA sequencing

When accuracy and precision matter

Start with the right controls. ATCC has made it a priority to provide ready-to-use nucleic acids from clinically relevant microorganisms and cell lines, allowing you to get your research and assay development started faster. Choose from:

  • Whole genome preparations
  • Synthetically derived DNA and RNA
  • Certified reference materials

With ATCC® Genuine Nucleics, you can trust that each preparation is fully authenticated and evaluated for integrity, purity, and quality using established techniques. So, let ATCC do the work for you! Browse our nucleic acid resources by clicking on the links provided below, or:


View our on-demand webinar to learn more about ATCC’s growing portfolio of quantitative nucleic acids that support infectious disease research, quality control testing, and the development of oncology molecular diagnostic tools.

Microbial Nucleic Acids

The extraction, preparation, and verification of nucleic acids can often require extensive amounts of time, labor, and expense. To save you time and money, ATCC has developed stabilized microbial nucleic acids preparations for use in inclusivity/exclusivity testing, establishing limits of detection, and validating or comparing test methods. Our portfolio of quantitative products includes:

Quantitative nucleic acids
Synthetic nucleic acids
Browse the complete collection

Cell Line Genomic DNA

Precision approaches to disease diagnostics and treatment as well as innovations in nucleic acid quantitation have enabled the creation of better tools for assay development. Accordingly, ATCC has developed purified and quantitative cell line genomic DNA (qDNA) with known mutation allelic frequency and gene copy number, which can provide a reliable and more sustainable alternative to patient tissue-derived controls for oncology molecular diagnostic assays.

Explore now

Certified Reference Materials

Genuine Nucleic CRMs are quantified biological reference materials produced under an ISO Guide 34:2009 accredited process to confirm identity, well-defined characteristics, and an established chain of custody. These tools are ideal for use in inclusivity/exclusivity testing, establishing limits of detection, and validating or comparing test methods.

Human KRAS Mutation DNA CRM
Quantitative Mycoplasma DNA CRM